title: [Latest developments on risk factors and prophylaxis of thromboembolic disease in obstetrics].
abstract: Venous thromboembolic disease and placental vascular pathology are responsible for an important maternal and foetal morbi-mortality with a modification of the hemostasis parameters. As these biological factors combined with particular clinical features can increase or reduce the risk of occurrence of these diseases, knowing the risk factors would help to prevent problems during the pregnancy. Several antithrombotic therapies exist, including very recent ones. Furthermore, a lot of recommendations are available in the literature. A lot of data are thus at our disposal but their synthesis is necessary to be really useful. We review here the risk factors, therapies and recommendations to help improve the management of these women.
authors.affiliation: Département d'obstétrique et gynécologie, hôpital Nord, CHU Saint-Étienne, avenue Albert-Raimond, Saint-Priest-en-Jarez, France. celine.chauleur@chu-st-etienne.fr
authors.forename: C
authors.initials: C
authors.lastname: Chauleur
authors.forename: J-C
authors.initials: JC
authors.lastname: Gris
authors.forename: P
authors.initials: P
authors.lastname: Seffert
authors.forename: P
authors.initials: P
authors.lastname: Mismetti
mesh_terms: D000328:Adult; D005260:Female; D005343:Fibrinolytic Agents; D006801:Humans; D010920:Placenta / Q000098:blood supply; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000517:prevention & control*; D012307:Risk Factors; D013923:Thromboembolism / Q000150:complications* / Q000517:prevention & control*; D014652:Vascular Diseases / Q000473:pathology / Q000517:prevention & control / Q000628:therapy
chemical_list: D005343:Fibrinolytic Agents